In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 5th, 2005 | 20 | No |
Popular Name: quinalizarin quinalizarin
1,2,5,8-tetrahydroxyanthracene-9,10-dione
1,2,5,8-TETRAHYDROXYANTHRAQUINONE
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.37 | 0.14 | -13.26 | 4 | 6 | 0 | 115 | 272.212 | 0 | ↓ |
Hi High (pH 8-9.5) | 2.37 | 1.06 | -48.74 | 3 | 6 | -1 | 118 | 271.204 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 5.49e-01 g/l | DrugBank-experimental |
therap | antiviral, HIV-1 integrase inhibitor | MicroSource Spectrum |
Patent Database Links | EP1808169; US2007191330 | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Q7ZJM1-1-V | Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral | Viruses | 4000 | 0.38 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Q7ZJM1_9HIV1 | Q7ZJM1 | Human Immunodeficiency Virus Type 1 Integrase, 9hiv1 | 1000 | 0.42 | Binding ≤ 1μM |
Q7ZJM1_9HIV1 | Q7ZJM1 | Human Immunodeficiency Virus Type 1 Integrase, 9hiv1 | 1000 | 0.42 | Binding ≤ 10μM |
No pre-computed analogs available. Try a structural similarity search.